e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Delayed and persistent suppression of bronchoconstriction by trypsin in the airway lumen
Sharma A., Goh H. L., Asokananthan N., Bakker A., Stewart G. A., Mitchell H. W.
Source:
Eur Respir J 2006; 27: 20-28
Journal Issue:
January
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sharma A., Goh H. L., Asokananthan N., Bakker A., Stewart G. A., Mitchell H. W.. Delayed and persistent suppression of bronchoconstriction by trypsin in the airway lumen. Eur Respir J 2006; 27: 20-28
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017
Mechanisms of bronchial hyperresponsiveness in a clinical setting – putative role of smooth muscle
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Endothelin receptor B protects GM-CSF mRNA from degradation in human airway smooth muscle cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Contribution of bronchial smooth muscle to inflammation
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Neutrophil elastase contributes to activated human neutrophil-induced rat small airway dysfunction
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Responses of bronchial smooth muscle to inflammation and disease
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Airway hyperresponsiveness development is related to airway smooth muscle cytosolic β1 integrin subunit expressing cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010
Physiological responses of the airway wall and lung in hyperresponsive pigs
Source: Eur Respir J 2001; 18: 935-941
Year: 2001
Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Effect of chronic stimulation of protease activating receptor-2 in human bronchial smooth muscle cells
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Distribution of increased airway smooth muscle thickness and airway inflammation in asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Role of thrombin and thrombin receptor in the activation of human bronchial epithelial cells during airway inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 523s
Year: 2007
The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique
Source: Eur Respir J 2008; 31: 532-538
Year: 2008
Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
A comparison of beta
2
-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Induction of proteinase-activated receptor-2 (PAR-2) expression by IL-1β and tryptase in human airway smooth muscle cells in culture
Source: Eur Respir J 2002; 20: Suppl. 38, 170s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept